Health

Advisory

CDC RECOMMENDS SUSPENSION OF ROUTINE USE OF 3RD AND 4TH DOSES OF PREVNAR

All health-care providers should temporarily suspend routine use of both the third and fourth doses of pneumococcal conjugate vaccine

(PCV7), the Centers for Disease Control and Prevention (CDC) recommended today. Children at increased risk of severe disease should

continue to receive the full, routine, four-dose series.

CDC took the action in consultation with the American Academy of Family Physicians (AAFP), the American Academy of Pediatrics (AAP), and

the Advisory Committee on Immunization Practices (ACIP), to most effectively use the limited, available doses of until the manufacturer

can restore full production. Wyeth Vaccines, the sole manufacturer in the United States, markets PCV7 under the trade name Prevnar®.

“CDC is concerned anytime children are not able to receive all of the recommended doses of a recommended vaccine,” said Dr.

Steve Cochi, acting director for the CDC’s National Immunization Program. “Delaying the third and fourth doses of this important

vaccine is not ideal; however, it is important to take steps to assure all children receive some protection with at least two doses of

vaccines.”

CDC had previously recommended that health-care providers temporarily suspend routine use the fourth dose. Since that recommendation was

issued, PCV7 production has been much less than had been expected and shipments have been further delayed, resulting in shortages of

vaccine. Widespread shortages may now continue beyond this summer.

“Four doses of PCV7 provide the best protection, but children who have received three doses should also have a very high level of

protection,” said Dr. Cochi. “Children who have had two doses should also have some protection, but the exact level is

unknown.”

Children whose third and fourth doses are delayed should receive the missed doses on their first visit to a healthcare provider after

supplies return to normal. Healthcare providers should keep track of children who are not able to get all of the recommended doses of the

vaccine and then contact those patients when they receive adequate supplies of vaccine.

Children with certain health conditions, such as sickle cell anemia or immune system disorders, are at increased risk of severe disease

and should continue to receive the full, routine, four-dose series.

The vaccine is normally recommended for young children in a four-dose schedule: one dose at 2 months, at 4 months, and at 6 months, and

one dose between 12 and 15 months. This recommendation suspends the third and fourth doses usually administered at 6 months and between

12 and 15 months for healthy children . PCV7 is not routinely recommended for children 2 years of age or older.

The vaccine can help prevent serious pneumococcal diseases, such as meningitis and blood infections. Pneumococcal infection can cause

serious illness and even death. Invasive pneumococcal disease is the leading cause of bacterial meningitis in the United States. Children

under two years of age are at highest risk. Before a vaccine was available, each year pneumococcal infection caused more than 700 cases

of meningitis, 13,000 blood infections and about 5 million ear infections.

WHY YOUR CHILD MAY HAVE TO WAIT TO GET HIS OR HER THIRD OR FOURTH DOSE OF PREVNAR®

VACCINE: FACTS FOR PARENTS

• At this time, there is a low supply of pneumococcal conjugate vaccine, also called Prevnar®. This vaccine protects childrenagainst serious disease and death caused by bacteria called Streptococcus pneumoniae.
• Because of low supplies, it is important to take steps to make sure all children get some Prevnar® vaccinations.
• While supplies are low, your healthcare provider has been asked to wait to give most children their 3rd and 4th doses of Prevnar®vaccine. Children whose 3rd or 4th dose is delayed should receive it on their first doctor’s visit after supplies return to normal.
• Four doses of Prevnar® vaccine provide the best protection, but your child will still have a very high level of protection if heor she has had three doses. Children who have had two doses of Prevnar® should also have some protection, but the exact level is not

  known.

• Children with certain health conditions, like sickle cell anemia or immune system disorders, are more prone to Streptococcuspneumoniae infections. Such children should still get all four shots.
• By temporarily not giving the third and fourth doses of Prevnar® vaccine to healthy children, healthcare providers will save manydoses of vaccine. As a result, there should be enough vaccine for all children to get at least two doses.
• Experts do not know exactly when supplies of Prevnar® vaccine will be back to normal. They expect supplies to be limited forseveral more months.

More Information

Vaccinating your children is one of the most important ways you can protect them from infectious diseases. Children should get certain

vaccines when they reach certain ages, according to the recommended immunization schedule. Vaccinating children on time helps to give

them the best protection possible.

Prevnar® is one of the vaccines in the recommended childhood immunization schedule. This vaccine protects against disease caused by

bacteria called Streptococcus pneumoniae. This bacteria can cause serious illness, including meningitis (an infection of the covering of

the brain), blood stream infections, and infection of the lungs. Streptococcus pneumoniae can infect anyone, but is most likely to cause

serious infection in infants and in children with certain medical conditions. Infants and toddlers should usually get four doses of

Prevnar®, one dose at 2 months, 4 months, 6 months, and 12-15 months of age.

Once in a while in the U.S., we do not have enough vaccine to vaccinate all children on time. When this happens, doctors may need to make

temporary changes in their patient’s vaccination schedules. This is done to help save vaccines and ensure that the children most in

need of protection get it. In February 2004, doctors and other experts became worried that the supply of Prevnar® would be low for

several months.

Steps have been taken by the vaccine manufacturer and the Centers for Disease Control and Prevention (CDC) in an attempt to prevent

healthcare providers from running out of Prevnar® vaccine. These steps have worked so far, but more needs to be done.

CDC, the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP) have decided to recommend that

doctors continue to give all children the first two doses of Prevnar® vaccine but that they stop, for now, giving healthy children

the third and fourth doses scheduled to be given at 6 months and 12-15 months of age.

Delaying the third and fourth doses of Prevnar® is not ideal. However, this step will help make sure that all children get at least

two doses of the vaccine. Doctors and other experts believe that giving all children two vaccinations will result in less disease than if

some children get 3 or 4 doses while others get none.

Children with certain health conditions that make them more prone to Streptococcus pneumoniae infections should still get all four shots.

Your healthcare provider can help determine if your child has a health condition that puts him or her at increased risk.

If we did not delay the 3rd and 4th doses of Prevnar® for most children, there would probably be widespread, serious shortages. If

this happened, some children might not get any doses of the vaccine. By not giving the third and fourth doses routinely, we expect to

save a large amount of vaccine so that all children will be protected with at least two doses.

CDC, AAP, and AAFP continue to watch the vaccine supply situation closely. No other routine childhood vaccines are in short supply so

your child should continue to receive all the other vaccines on the normal schedule. More information about vaccine shortages is

available at:  www.cdc.gov/nip/news/shortages. Information about what vaccines

your child should receive can be found at: www.cdc.gov/nip/kidstuff

For more information, visit:  www.cdc.gov/nip, or call the CDC National Immunization

Information Hotline (800) 232-2522 (English), (800) 232-0233 (Español), or (800) 243-7889 (TTY)